DRRT – GLOBAL SECURITIES LITIGATION, INSTITUTIONAL CLAIMS FILING AND LITIGATION SUPPORT

DRRT – GLOBAL SECURITIES LITIGATION, INSTITUTIONAL CLAIMS FILING AND LITIGATION SUPPORT

GLOBAL SECURITIES LITIGATION, INSTITUTIONAL CLAIMS FILING AND LITIGATION SUPPORT

  • English
    • Français
    • Deutsch
    • 日本語
    • Italiano
    • Español
    • 简体中文
GPS Secure Login
Forgot Password?
  • Home
  • Our Firm
    • Overview
    • DRRT Advantages
    • Security and Compliance
    • Why Choose Us
    • Significant Recoveries
  • Our Team
    • Attorneys
    • Firm Leadership
  • Areas of Expertise
    • Global Securities Litigation
      • U.S. and Canadian Securities Litigation
      • International Securities Litigation
      • Financial Antitrust Litigation
      • Arbitration and Alternative Dispute Resolution
    • Institutional Claims Filing
  • Cases
    • Global Securities Litigation
      • Open Cases
      • Filed Cases
      • Track Record
        • U.S. Cases
        • Non-U.S. Cases
    • Institutional Claims Filing
      • U.S./Canadian Securities Class Actions
      • Securities-Related Antitrust Class Actions
      • Dutch Foundation Settlements
      • Australian Securities Class Actions
      • Insolvency Proceedings
  • Events
    • Upcoming Events
    • Past Events
  • News
    • News, Articles & Publications
    • DRRT’s Global Loss Recovery Blog
  • Corporate Social Responsibility
  • Contact Us

Current Settlements |

  • General Electric Company (SEC FAIR FUND), $200,000,000 Deadline: 10/19/2022
  • Facebook, Inc. (n/k/a Meta Platforms, Inc.) (SEC), $100,000,000 Deadline: 10/26/2022
  • Mallinckrodt plc (2017), $65,750,000 Deadline: 10/27/2022
  • Euro Interbank Offered Rate (Antitrust), $364,000,000 Deadline: 11/03/2022
  • Walgreen Co. (2015) (n.k.a Walgreens Boots Alliance Inc.), $105,000,000 Deadline: 11/05/2022
  • Twitter, Inc. (N.D. Cal.) (2016), $809,500,000 Deadline: 11/23/2022
  • SIBOR- and/or SOR-Based Derivatives (Antitrust), $155,458,000 Deadline: 12/29/2022
  • Bank Bill Swap Rate Based Derivatives (Antitrust), $185,875,000 Deadline: 01/16/2023

Past Events

  • Upcoming Events
  • Past Events
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 5th Institutional Investor Roundtable in Tokyo
    5th Institutional Investor Roundtable in Tokyo
    January 30, 2017
  • 9th Annual European Conference 2017 in Frankfurt
    9th Annual European Conference 2017 in Frankfurt
    February 06, 2017
  • 6th Institutional Investor Roundtable in Boston
    6th Institutional Investor Roundtable in Boston
    April 20, 2017
  • 3rd Institutional Investor Roundtable in New York
    3rd Institutional Investor Roundtable in New York
    April 21, 2017
  • 1st Institutional Investor Roundtable in Chicago
    1st Institutional Investor Roundtable in Chicago
    April 25, 2017
  • 2nd Institutional Investor Roundtable in Milan
    2nd Institutional Investor Roundtable in Milan
    May 24, 2017
  • 1st Institutional Investor Roundtable in Paris
    1st Institutional Investor Roundtable in Paris
    June 01, 2017
  • 1st Institutional Investor Roundtable in Luxembourg
    1st Institutional Investor Roundtable in Luxembourg
    June 02, 2017
  • 8th Institutional Investor Roundtable in London
    8th Institutional Investor Roundtable in London
    June 05, 2017
  • 4th Institutional Investor Roundtable in Edinburgh
    4th Institutional Investor Roundtable in Edinburgh
    June 06, 2017
  • 6th Institutional Investor Roundtable
    6th Institutional Investor Roundtable in Tokyo
    October 18, 2017
  • Miami
  • Frankfurt
  • Paris
  • London

DRRT Privacy Policy

© 2022 DRRT, all rights reserved by Alexander Reus, P.A. dba DRRT, a limited partner of Diaz Reus & Targ LLP. No information on drrt.com site constitutes legal advice. The selection of legal counsel is an important decision. Contacting DRRT via its website does not create an attorney-client relationship.

Ethics and Compliance

DRRT has a “Ethics and Compliance” email available to all clients, contractors, vendors, and others involved in any business relationship with DRRT. The Ethics and Compliance email is a reporting mechanism that facilitates reporting of possible illegal, unethical, or improper conduct when escalation has proven ineffective or is impractical under the circumstances. While we hope there will be no need for this, should you ever need to report any unethical behavior or any complaints, please send an email to ethics@drrt.com.